The verified answer
As of Aug 2026, DEPLOY verifies Lifeward: 2 models, 2 deployments across 2 regions, 3 active incidents. 5 sources back the record.
Lifeward holds 2 FDA 510(k) clearances, per the DEPLOY registry.
See all 2 filingsCategoryExoskeletons
Overview
Lifeward (formerly Rewalk robotics, Nasdaq: LFWD) is an Israeli-American medical device company founded in 2001 by Dr. Amit Goffer, a quadriplegic inventor who developed the exoskeleton after an ATV accident. The company designs and commercializes powered exoskeleton systems for individuals with spinal cord injury, including the ReWalk 7 Personal Exoskeleton (FDA-cleared March 2025) and the ReWalk Personal 6.0. Lifeward's portfolio also includes the AlterG Anti-Gravity System, ReStore Exo-Suit, and MyoCycle FES System, with operations in the US, Israel, and Germany.
Verified record
- Verified deployments
- 2 deployments on file
- Active incidents
- 3 incidents on file
Key facts
CEO
Previous CEO
CFO
Founder
Revenue 2024
Units deployed
FDA clearance
Medicare
Operations
Product portfolio
Data & sources
Company filings
1
Press releases
3
Web sources
1
5 sources backing this record.View all →
Models (2)
View all models →Current platform
ReWalk 7
Powered lower-limb personal exoskeleton; latest ReWalk generation, FDA cleared March 2025. Motor-driven powered gait for spinal-cord-injury users.
Current platform
ReWalk Personal 6.0
ReWalk's Personal 6.0 is a powered lower-limb exoskeleton for individuals with spinal cord injury; servos at the hips and knees provide walking power, while accelerometers detect weight shifts to trigger each step. The onboard computer, sensors, and batteries are carried in a slimmed-down pack.
Partnerships
Every company Lifeward has built with, alongside the ones only announced in a press release.
Lifeward on the deployment map
View the global map2 verified deployments across 2 regions, newest verified Jun 2024. Explore where Lifeward's robots are operating, by place and type.
View the full Lifeward deployment record →
Relationships
Current leadership (5)
- Mark Grant President & CEO
- Mike Lawless CFO
- Joseph Turk Chairman of the Board
- Larry Jasinski CEOsince 2012-01-01secondary-verified
- Amit Goffer Founder & Chief Innovation Officersince 2001-01-01secondary-verified
Founders (3)
- Amit Goffersolefounded 2001-01-01no longer at company
later founded ReWalk Robotics
- Amit Goffersoleno longer at company
later founded ReWalk Robotics
- Dr. Amit Gofferno longer at company
Former / Previously (1)
- Dr. Amit Goffer Founder & Inventor
Safety record
2 recalls and 1 incident on record (3 serious). Most recent: Feb 2020.
Most recent: Feb 2020
Only active incidents are counted. Retracted incidents are excluded from this summary but remain reachable at their canonical URLs.
Full safety record: incidents, sourcing, and exposure data →
Incidents affecting Lifeward (3)
Includes incidents linked directly to this company, to its models, or to deployments of its models or under its operation. Retracted incidents are excluded from this view but remain reachable at their canonical URLs.
Operator customers (1)
- Lifeward2 deployments
Recent coverage
Lifeward in third-party press
Peers
26 peers across 1 segment. Every Lifeward competitor derived from shared form-factor and application-domain edges.
exoskeleton(26)
23 companies in this segment · highly_concentrated (HHI 5009.45179584121) · leader Hypershell at 5217%
- ATOUNdirect competitor(inferred)moderate
- Againer Skidirect competitor(inferred)moderate
- B-TEMIAdirect competitor(inferred)moderate
- Bionik Laboratoriesdirect competitor(inferred)moderate
- Cyberdynedirect competitor(inferred)moderate
- Daiya Industry Co., Ltd.direct competitor(inferred)moderate
Supplied by (1)
Actuators & motors
- maxon Groupvia ReWalk Personal 6.0RE 40 brushed DC motors + GP 42 C planetary gearheads (ceramic), four units (hip + knee)supplies
Inbound supply edges feeding this company directly or via the models it owns. Same source bar as the outbound view (verified against at least two strong sources).
Financial state
- Reporting basis
- aggregator_estimate
- Lifecycle stage
- mature
- Counterparty risk class
- low
Each numeric field carries its own basis marker. Aggregators report a number; this surface preserves the source class so verification depth travels with the value.
Partnerships
2 total · 2 operating
Every company Lifeward has built with, alongside the ones only announced in a press release.
All 2 partnerships
open in the atlas →- lifeward x nvidiawithNVIDIA1108technology—operating
- lifeward x awswithAWS976technology—operating
Regulatory filings (2)
- K241822fda 510k · us_fdacleared2024-06-24
Linked models: ReWalk 7
- fda_510kfda 510k · us_fdacleared2014-06-26
Linked models: ReWalk Personal 6.0
Timeline
Every recorded move in Lifeward’s history, most recent first: funding rounds, partnerships, acquisitions, supply-chain starts, key hires, and press.
Key hireAmit Goffer joins as Founder & Chief Innovation Officer
2001-01-01Amit Goffer appointed Founder & Chief Innovation Officer (current)
Recent activity
Every change to this record is dated, sourced, and independently verified where marked.
- Verified media addedVerifiedJun 6, 2026
ReWalk Personal 6.0: how it works
- Verified media addedVerifiedJun 6, 2026
ReWalk 7 personal exoskeleton
- Record createdJun 6, 2026
Added to the verified registry
- Deployment verifiedVerifiedJun 1, 2024
ReWalk 7 at United States
- Deployment verifiedVerifiedJun 1, 2024
ReWalk Personal 6.0 at Marlborough
Sources (5)
- https://ir.rewalk.com/news-releases/news-release-details/rewalk-robotics-transforms-company-identity-rebrands-lifeward
- https://golifeward.com/blog/rewalk-personal-exoskeleton-system-clearned-fda-home-use/
- Lifeward Names Mark Grant as New CEO · https://ir.rewalk.com/news-releases/news-release-details/lifeward-names-mark-grant-new-ceo
- Lifeward Launches Sales of the ReWalk 7 Personal Exoskeleton in U.S. Market · https://golifeward.com/blog/lifeward-launches-sales-of-the-rewalk-7-personal-exoskeleton-in-u-s-market/
- Lifeward Ltd. SEC Filing 2025 · https://www.sec.gov/Archives/edgar/data/1607962/000117891325000736/zk2532799.htm
Common questions
What is Lifeward?
What does Lifeward make?
Is Lifeward publicly traded?
Who competes with Lifeward?
Who is the CEO of Lifeward?
How can I invest in Lifeward?
Where is Lifeward headquartered?
Who owns Lifeward?
Where does Lifeward operate robots?
How many robots has Lifeward deployed?
Is Lifeward a top robotics company?
When was Lifeward founded?
Are there any incidents involving Lifeward?
Is Lifeward safe?
Methodology: Verified · 5 sources (4 primary) · last reviewed 2026-08-21
Verification posture
Verified
High confidence
Review state
Stable
Last reviewed 2026-08-21
Sources by quality tier
- 3
- primary-company-ir
- Company IR disclosure
- 1
- unclassified
- Unclassified source
- 1
- primary-sec-filing
- SEC filing
The framework is documented at /methodology. Corrections at /corrections. Reviewer: DEPLOY editorial team.
Methodology surface for Lifeward.Peer companies
- Fourier Intelligence4 models
- Honda3 models
- Lockheed Martin3 models
- Ascentiz2 models
- DIH Medical2 models
- Ekso Bionics2 models
In the press
Recent coverage mentioning Lifeward from third-party publications. Automatically surfaced; not part of the verified registry record.
Lifeward's ReWalk Personal Exoskeleton Now Covered by Aetna
Aetna approves coverage for the ReWalk Personal Exoskeleton System, an FDA-approved technology for individuals with spinal cord injury, expanding insurance access.
First Major U.S. Commercial Health Insurer Approves Purchase of ReWalk 7 Personal Exoskeleton
A major US commercial health insurance company approves payment for a ReWalk 7 Personal Exoskeleton for one of its beneficiaries, expanding access beyond Medicare.
Lifeward Names Mark Grant as New CEO
Lifeward appoints Mark Grant, former Medtronic VP, as new CEO effective June 2 2025, replacing Larry Jasinski who transitions to advisory role.
Lifeward Launches Sales of the ReWalk 7 Personal Exoskeleton in U.S. Market
Lifeward launches the ReWalk 7 Personal Exoskeleton nationwide in the US, featuring cloud connectivity, customizable walking speeds, and FDA clearance received in March 2025.
FDA Issues Clearance for ReWalk 7 Exoskeleton
Lifeward receives FDA clearance for the ReWalk 7 Personal Exoskeleton, building on the company historic first FDA clearance for a personal exoskeleton in 2014.
Machine-readable surfaces
- Markdown mirror: /companies/lifeward.md
- RSS feed: /companies/lifeward/feed.xml
- JSON-LD: embedded in this page’s head
- REST API: /v1/companies/4421900a-d71f-407e-a37c-ad1e3905e97f
- Revision history: /companies/lifeward/history
- Data documentation: /data
- Query this programmatically: Deploy MCP
Peer companies
- Fourier Intelligence4 models
- Honda3 models
- Lockheed Martin3 models
- Ascentiz2 models
- DIH Medical2 models
- Ekso Bionics2 models
Video
ReWalker Katarina performs Sit-to-Stand and Stand-to-Sit transfers in her ReWalk Personal 6.0 Exoskeleton
The ReWalk Exoskeleton system enables people with spinal cord injuries to walk upright again.
ReWalker Gene L. received his own ReWalk Exoskeleton in 2015, and first tried the device in a research study at his Veterans Affairs (VA) Hospital in 2012. The
Ein kurzes Infovideo, welches die ReWalk Test Session zusammenfasst und aufzeigt, was Sie erwarten könnte. Sie wollen mehr erfahren? Dann besuchen Sie unsere
Smarter, smoother, more powerful. Learn more at golifeward.com/rewalk7
Explore the groundbreaking world of Lifeward, where innovation meets inspiration. In this video, we delve into how Lifeward is pushing the boundaries of technol
ReWalk Robotics is proud to offer a comprehensive family of neurorehabilitation solutions for both in-clinic and at-home use. Learn more about our rehabilitatio
Learn the roles & responsibilities of acting as a ReWalk Companion
Introducing Lifeward, previously ReWalk Robotics. Our mission at Lifeward is to relentlessly drive innovation to change the lives of individuals with physical
Introducing Lifeward, previously ReWalk Robotics. Our mission at Lifeward is to relentlessly drive innovation to change the lives of individuals with physical
Hear from Professor Shuo-Hsiu (James) Chang, PT, PhD as he talks through some of his ideas on how robotic technology can be introduced in SCI rehabilitation in
Hear from Dr. Esquenazi, CMO of MossRehab, as he discusses the key principles and limitations of traditional locomotor training programs in neurorehabilitation,
Reality vs attention
Lifeward draws attention at the 65th percentile but verifies reality at the 41st percentile among exoskeletons. Hype Gap +23.9, 13th widest among exoskeletons.
6-month trend
Analysis
Safety profile within acceptable range for category. Limited public funding data for capital position assessment.
Signal flags
Dimension breakdown
Verified signal
Attention (reach, not merit)
DEPLOY Intelligence scores are computed from verified registry data: confirmed deployments, disclosed funding rounds, regulatory filings, active job listings, video viewership, and press coverage. Confidence ratings reflect data availability. Scores update nightly.
DEPLOY Indices — verified vs claimed
Last computed: Aug 29, 2026